ArticleOncology letters2017

Combination of lenalidomide and low-dose dexamethasone therapy promotes the anticoagulant activity of warfarin in patients with immunoglobulin light-chain amyloidosis.

Fumiaki Kitazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.